Clinical Trials Browser

Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal, Neuroectodermal Tumors, Primitive, Peripheral

NCT01090765 2018-05-22

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

Phase 1/2 Completed

21 enrolled 17 charts

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT01174264 2017-05-19

Evaluation of Food Effect on Pharmacokinetics of Vismodegib

Phase 1/2 Completed

63 enrolled 21 charts

Tumor-Agnostic

Neoplasms

NCT00924287 2015-10-28

Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

Phase 1/2 Terminated

1 enrolled 8 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00166686 2013-01-11

Clonidine for Neurocognitive Sequelae

Phase 1/2 Withdrawn

Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

NCT00924001 2012-10-25

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Phase 1/2 Terminated

1 enrolled 8 charts

Dermatologic

Melanoma, Melanoma, Experimental, Neoplasms

Clinical Trials

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Magnesium Supplementation in People With XMEN Syndrome

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

Evaluation of Food Effect on Pharmacokinetics of Vismodegib

Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

Clonidine for Neurocognitive Sequelae

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma